Rating date
Jun 16, 2026
55 days ago
NVIDIA (NVDA) Stock Analysis
OWNVDA Equity Research — OVERWEIGHT — June 2026
Desk view
OW
5D move
—
Awaiting market data
Peer rank
32p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · NVDA
Here is the analysis of NVDA as of June 16, 2026.
Desk rating
OW
Tactical OW · 12M OW
Horizon
Long-term
Confidence
Low
Invalidation
For a 12-month view, the upside from here is more likely than not, but the macro and insider signals warrant a measured, stepwise approach rather than aggressive accumulation. Hence Overweight – favorable conviction with a gradual build.
Bias
OVERWEIGHT
Catalysts
- Bullish long-term structure intact: Price above both the 50- and 200-day SMAs, with a positive SMA slope.
- Short-term corrective pressure is real: MACD bearish crossover, RSI below 50, and price declining from May highs form a coherent picture of a pullback in progress.
- Support zone near $200–$205: The June 10 low ($200.42) and June 5 close ($205.10) mark a band of recent support. A break below $200 would test the 50-day SMA ($208.01) from below and then the 200-day SMA (~$189).
Risks
- For a 12-month view, the upside from here is more likely than not, but the macro and insider signals warrant a measured, stepwise approach rather than aggressive accumulation. Hence Overweight – favorable conviction with a gradual build.
Market chart
Price context alongside the research narrative.
NVDA Research Note
Full desk note for Jun 16, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
NVDA Equity Research Note
NVDA Stock Rating Summary
NVDA bias
OVERWEIGHT
Horizon
Long-term
NVDA key risk
For a 12-month view, the upside from here is more likely than not, but the macro and insider signals warrant a measured, stepwise approach rather than aggressive accumulation. Hence Overweight – favorable conviction with a gradual build.
NVDA catalyst watch
Bullish long-term structure intact: Price above both the 50- and 200-day SMAs, with a positive SMA slope.
Invalidation
For a 12-month view, the upside from here is more likely than not, but the macro and insider signals warrant a measured, stepwise approach rather than aggressive accumulation. Hence Overweight – favorable conviction with a gradual build.
Confidence
Low
How the call aged · 5D
—Awaiting market dataPeer 32pExpandCollapse
How the call aged · 5D
—Awaiting market dataPeer 32p
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-17T07:48:34.404550+00:00.
5D move
—
2026-06-16 → awaiting
Outcome
Awaiting market data
5D trend
-0.37%
Vol (20D ann.)
+42.91%
vs SPY: -2.18%
Close 207.41 → — (USD, vendor closes)
Batch scorecard · 2026-06-16 · NVDA
Publish QC
passedExpandCollapse
Publish QC
passed
Pipeline fingerprint 2f45a102687f75c0
Trace 77d353da…
No QC issues recorded.